Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Millennium Pharmaceuticals, Inc
Woman and Man Max 99 years
Millennium Pharmaceuticals, Inc
Update Il y a 4 ans
Brentuximab vedotin+Adriamycin, vinblastine, and dacarbazine in pediatric patients with advanced stage newly diagnosed Hodgkin lymphoma Brentuximab Vedotin+Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
Phase 1 Primary Objective: To assess the safety and tolerability, and to identify the recommended dose of brentuximab vedotin when combined with multiagent chemotherapy regimen AVD for first-line tr...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Millennium Pharmaceuticals, Inc
Update Il y a 4 ans
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study of the Efficacy, Safety, and Pharmacokinetics of MLN3897 in Patients with Rheumatoid Arthritis Taking Methotrexate
This is the first study of MLN3897 in any disease population. It seeks to establish: • The ability of MLN3897 to modify the signs and symptoms of rheumatoid arthritis (RA) • The safety and tolerabilit...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Update Il y a 4 ans
The aim of the study is to provide patients with certain kinds of cancer continued access to the same drug they have received in a previous study, if they have benefited from the use of the drug. El objetivo de este estudio seguir ofreciendo a los pacientes acceso al mismo medicamento que han venido recibiendo en un estudio previo, si han tenido beneficio del uso del medicamento
Primary Objective: To provide continued access of ixazomib and to evaluate the long-term safety profile of ixazomib. Objetivo Principal: Seguir ofreciendo acceso a ixazomib y evaluar la segurida...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3